Director, CIPDD


School of Biomedical Sciences


The University of Queensland



Prof. Maree T. Smith


Maree Smith AC, is Emeritus Professor and Director of the Centre for Integrated Preclinical Drug Development (CIPDD) in the School of Biomedical Sciences at The University of Queensland. Internationally, she is a leading researcher in biomedical discovery/translation with particular expertise in the novel pain therapeutics field. She is inventor on a patented novel analgesic technology that was licensed to the UQ spin-out company, Spinifex Pharmaceuticals, for commercialization and acquired by Novartis in 2015. Although her focus is on IP-sensitive research, she has maintained an excellent publication output, with >180 publications to date. She has also advised/co-advised 33 PhD students and more than 50 Research Masters/Honours students to completion, as well as mentored numerous researchers in the past three decades.


Wednesday, September 21, 2022

10:45am EDT12:15pm EDT

Angiotensin Receptor Signaling as a Pain Target: Bench, Bedside and Back-Translation

Tracks: Mechanisms
Categories: Topical Workshop
Room: 718 B

The major bioactive molecule in the renin-angiotensin system, the peptide hormone angiotensin II orchestrates many more processes than blood pressure…

Friday, September 23, 2022

8:15am EDT9:30am EDT

Nonopioid Analgesics Discovery and the Valley of Death – EMA401 from Concept to Clinical Trial

Categories: Plenary Lecture, Virtual Program
Presented By: Prof. Maree T. Smith
Room: Plenary Room Level 800

Success in translating promising preclinical efficacy data for molecules from novel non-opioid analgesics discovery programs to positive clinical trial outcomes…